Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...
Equity portfolio teams must ask questions to determine where the narrative is overdone in a software industry facing ...
No revenue was recognized in Q4 from products currently under NPD, as these remain in the development phase. Kirsten Newquist ...
Silvaco Group surged over 50% post-Q4 FY25 earnings last week, driven by strong TCAD bookings and explosive SIP revenue ...
Revenue of $481 million increased 14 percent year-over-year ARR of $1.853 billion increased 11 percent year-over-year GAAP ...
Secured second artificial intelligence-driven machine learning (AI/ML) FTCO™ customer, driving revenue above high end of guided range -- ...
Clover Health Investments (NASDAQ:CLOV) executives outlined what they described as a repeatable, technology-driven Medicare ...
Solo Brands, Inc. (NYSE: SBDS) ('Solo Brands” or 'the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, ...
(NYSE: S) today announced financial results for the fourth quarter and fiscal year 2026 ended January 31, 2026. "We surpassed the $1 billion revenue milestone, growing 22% year-over-year, and achieved ...
Atlassian (NasdaqGS:TEAM) announced a 10% workforce reduction as part of a broad restructuring focused on artificial ...
Palantir Technologies (NASDAQ: PLTR) is trading at $157.39 on Monday, March 23, 2026 — up approximately 4.5% on the session as the broad tech rally driven by Trump's Iran ceasefire announcement lifted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results